Ventura L - Search Results

1

ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma.

Gravina GL, Colapietro A, Mancini A, Rossetti A, Martellucci S, Ventura L, Di Franco M, Marampon F, Mattei V, Biordi LA, Otterlei M, Festuccia C. Gravina GL, et al. Among authors: ventura l. Cancers (Basel). 2022 Jan 7;14(2):289. doi: 10.3390/cancers14020289. Cancers (Basel). 2022. PMID: 35053455 Free PMC article.

2

In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma.

Festuccia C, Gravina GL, Muzi P, Pomante R, Ventura L, Ricevuto E, Vicentini C, Bologna M. Festuccia C, et al. Among authors: ventura l. Prostate. 2007 Sep 1;67(12):1255-64. doi: 10.1002/pros.20616. Prostate. 2007. PMID: 17596848

3

Bicalutamide increases phospho-Akt levels through Her2 in patients with prostate cancer.

Festuccia C, Gravina GL, Muzi P, Pomante R, Ventura L, Vessella RL, Vicentini C, Bologna M. Festuccia C, et al. Among authors: ventura l. Endocr Relat Cancer. 2007 Sep;14(3):601-11. doi: 10.1677/ERC-07-0118. Endocr Relat Cancer. 2007. PMID: 17914091

4

A feasibility study of percutaneous Radiofrequency Ablation followed by Radiotherapy in the management of painful osteolytic bone metastases.

Di Staso M, Zugaro L, Gravina GL, Bonfili P, Marampon F, Di Nicola L, Conchiglia A, Ventura L, Franzese P, Gallucci M, Masciocchi C, Tombolini V. Di Staso M, et al. Among authors: ventura l. Eur Radiol. 2011 Sep;21(9):2004-10. doi: 10.1007/s00330-011-2133-3. Epub 2011 May 1. Eur Radiol. 2011. PMID: 21533865

5

Hormonal therapy promotes hormone-resistant phenotype by increasing DNMT activity and expression in prostate cancer models.

Gravina GL, Marampon F, Piccolella M, Motta M, Ventura L, Pomante R, Popov VM, Zani BM, Pestell RG, Tombolini V, Jannini EA, Festuccia C. Gravina GL, et al. Among authors: ventura l. Endocrinology. 2011 Dec;152(12):4550-61. doi: 10.1210/en.2011-1056. Epub 2011 Oct 11. Endocrinology. 2011. PMID: 21990314 Free PMC article.

6

CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.

Gravina GL, Mancini A, Muzi P, Ventura L, Biordi L, Ricevuto E, Pompili S, Mattei C, Di Cesare E, Jannini EA, Festuccia C. Gravina GL, et al. Among authors: ventura l. Prostate. 2015 Sep;75(12):1227-46. doi: 10.1002/pros.23007. Epub 2015 Jun 12. Prostate. 2015. PMID: 26073897

7

KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models.

Gravina GL, Mancini A, Sanita P, Vitale F, Marampon F, Ventura L, Landesman Y, McCauley D, Kauffman M, Shacham S, Festuccia C. Gravina GL, et al. Among authors: ventura l. BMC Cancer. 2015 Dec 1;15:941. doi: 10.1186/s12885-015-1936-z. BMC Cancer. 2015. PMID: 26620414 Free PMC article.

8

Erratum to: KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models.

Gravina GL, Mancini A, Sanita P, Vitale F, Marampon F, Ventura L, Landesman Y, McCauley D, Kauffman M, Shacham S, Festuccia C. Gravina GL, et al. Among authors: ventura l. BMC Cancer. 2016 Jan 11;16:8. doi: 10.1186/s12885-015-2046-7. BMC Cancer. 2016. PMID: 26753765 Free PMC article. No abstract available.

9

HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells.

Marampon F, Megiorni F, Camero S, Crescioli C, McDowell HP, Sferra R, Vetuschi A, Pompili S, Ventura L, De Felice F, Tombolini V, Dominici C, Maggio R, Festuccia C, Gravina GL. Marampon F, et al. Among authors: ventura l. Cancer Lett. 2017 Jul 1;397:1-11. doi: 10.1016/j.canlet.2017.03.028. Epub 2017 Mar 23. Cancer Lett. 2017. PMID: 28342984

10

Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models.

Gravina GL, Mancini A, Mattei C, Vitale F, Marampon F, Colapietro A, Rossi G, Ventura L, Vetuschi A, Di Cesare E, Fox JA, Festuccia C. Gravina GL, et al. Among authors: ventura l. Oncotarget. 2017 May 2;8(18):29865-29886. doi: 10.18632/oncotarget.16168. Oncotarget. 2017. PMID: 28415741 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

547 results

Search Page